I think you're probably right, but then there is the Regeneron product, which got way more (not a high bar there) press back then than leronlimab. I believe Trump got the Regeneron monoclonal antibodies back in Oct 2020 under compassionate use. It's possible that Makary was referring to that and may not have gotten wind of leronlimab. Maybe Dr Jay should give him a call.